News

MedTech Intelligence: Preserving Native Kidney Function: The Ultimate Goal in Kidney Care

The Hidden Entrepreneur: From Crazy Idea to Life-Saving Innovation

LSI: The Weekly Recap 1/10/25: LSI Alumni Achievements Driving Medtech and Healthtech Forward

Third News: FDA Approval for Pivotal Trial of Innovative JuxtaFlow® Renal Assist Device Marks Significant Milestone in Kidney Health

Mass Device: Roivios wins FDA IDE for renal assist device

Nephrology Times: Promising Data on JuxtaFlow Renal Assist Device

MPO-Mag: Roivios Releases Clinical Data on the JuxtaFlow RAD

Renal Interventions: Roivios unveils promising new clinical data on the JuxtaFlow Renal Assist Device.

Biospace: Roivios Unveils Promising New Clinical Data on the JuxtaFlow® Renal Assist Device (RAD)

Pulse 2.0: Roivios: Interview with CEO John Erbey on Innovative Treatments Transforming Kidney Health Management

MedCity News: Innovations Shaping the Future of Renal Care

Nephrology Times/DocWire News: Promising Data on JuxtaFlow Renal Assist Device

Dr. Erkeda DeRouen LinkedIn Live

David Meltzer Office Hours

Passionate Pioneers

Medical Product Outsourcing (MPO) Mag, Roivios Receives FDA Breakthrough Device Designation for JuxtaFlow RAD

Mass Device: Roivios wins FDA breakthrough nod for renal assist device

DocWire News, Renal Device for Use in Cardiac Surgeries Gets FDA Breakthrough Designation

Roivios Receives FDA Breakthrough Device Designation for JuxtaFlow RAD

Roivios Wins FDA Breakthrough Nod for Renal Assist Device

Roivios® announces final patient enrollment in feasibility trial for JuxtaFlow® Renal Assist Device (RAD)

RoiviosTM announces first patient enrolled in feasibility trial for JuxtaFlow® Renal Assist Device (RAD)

Check back here for the latest news and updates on our BIPASS-AKI clinical study and the JuxtaFlow^® Renal Assist Device System.

Learn about our research

Find info about our clinical studies

Meet our Team

See what makes us different

Contact Us

Connect with our team